Home
  • English
  • Deutsch
FENS Forum 2026
Göttingen Meeting 2027
FENS

2nd Edition of International Cancer and Precision Oncology Conference

Home / Node / 2nd Edition of International Cancer and Precision Oncology Conference
2nd Edition of International Cancer and Precision Oncology Conference
ICPOC 2026
Mon, 23/11/2026 to Wed, 25/11/2026
City: 
Singapore
Country: 
Singapore

Contact

Scientific organizer: 
Mathews International llc
Contact address: 
Village Hotel Changi 1 Netheravon Rd, Singapore 508502
Phone: 
3124624448
Description: 

Advancements in personalized oncology demand global collaboration, and ICPOC 2026 responds to this need through international scientific engagement. The 2nd International Cancer and Precision Oncology Conference is scheduled for November 23-25, 2026, in Singapore, with extended reach via online scientific access.
ICPOC 2026 is curated for oncology specialists, biomedical researchers, genomic scientists, healthcare professionals, and industry experts focused on patient-specific cancer care. The Precision Oncology Conference emphasizes translational research and precision-guided therapeutic innovation.
Scientific discussions cover molecular cancer characterization, targeted treatment pathways, immuno-oncology development, biomarker-driven diagnostics, and data-supported clinical strategies. Sessions encourage integration of research findings into clinical decision-making.
Participants attending through virtual participation channels will receive live access to expert lectures, academic discussions, and interactive content delivered through a digital platform designed for professional engagement.
Upcoming Oncology Conferences supports interdisciplinary collaboration by connecting academia, healthcare systems, and biomedical industries. The Cancer Conference also promotes knowledge sharing that advances precision oncology research and application.
With a combination of in-person interaction and remote conference engagement, ICPOC 2026 ensures flexibility for global audiences. The event remains a significant educational initiative for professionals advancing individualized cancer treatment approaches.